Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page
- Check6 days agoChange DetectedAdded Cali, Colombia, 760043 as a study location and removed Santiago de Cali, Colombia, 760043 from the locations list. This updates the Contacts and Locations section to reflect current recruitment sites.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%

- Check35 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check50 days agoChange DetectedLocation label updated from Mexico, Mexico, 06700 to México, Mexico, 06700 to reflect localization. The release version is now v3.0.2, and the Back to Top link was removed.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%

- Check64 days agoChange DetectedThe web page has been updated to include a new facility name and location details, as well as a comprehensive list of publications related to the study, while some previous location entries have been removed.SummaryDifference22%

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.